How do I follow up on an unpaid invoice without damaging the relationship?

Assume a process issue first. Put the facts up top, offer to fix coding or PO problems, and keep the tone operational. Escalate to the original buyer only after AP has had a fair chance. Rage emails get paid last.

Is it okay to send this proposal follow-up on LinkedIn instead of email?

Yes if this CEO is actually active there and the thread isn't about long attachments. Keep the LinkedIn version even shorter. Don't paste the full email. One context line and one question is plenty. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

What should I never say in a Pharmaceuticals proposal follow-up?

Don't use consumer-startup slang. It's a credibility leak. A long origin story or a request to 'pick your brain.' Don't threaten, guilt, or bury the amount. Those three mistakes show up constantly in Pharmaceuticals inboxes and they all read as "this was templated."

Can I use aggressive sales language in pharma outreach?

No. Unapproved claims, off-label hints, and fake urgency can create real problems. Be operational: timelines, review status, access, meeting logistics. Save clinical discussion for approved materials and the right role. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

How should a proposal follow-up to a Pharmaceuticals CEO change for after an invoice?

Neutral and factual. Warmth without jokes. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. The CEO is guarding time, reputation, and optionality, so the ask should stay at "one decision or a 10-minute yes, not a workshop." If you copy a generic template and only swap the

Pharmaceuticals · CEO · After Invoice

Proposal Follow-Up for Pharmaceuticals CEO: After Invoice

A proposal follow-up email for a Pharmaceuticals CEO (after an invoice) is a short message that reopens the thread without making them do extra work. A proposal follow-up email helps a stalled decision move without pretending the document didn't land. In this setting, that means speaking to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick

Last updated: 2026-09-02 · Reviewed by: Sales Email Template editors

We write templates the way we wrote emails on quota: short, specific, and easy to forward. When we cite research below, it is because the number changes how a buyer reads your note, not to pad the page.

Sources: HubSpot sales email benchmarks; Gong follow-up research

Why does this proposal follow-up work for a Pharmaceuticals CEO?

Give them a clean no so they don't ghost out of politeness.
Speaks to follow-up that ignores MLR, off-label risk, and the fact that 'just a quick claim' isn't quick instead of a generic "value prop."
Fits how a CEO actually reads: Keep the whole note under 70 words unless they asked for detail.
Restate number, due date, invoice ID, and pay path in the first screen.
Offer a smaller package so budget isn't a binary wall.

When should I send this to a Pharmaceuticals CEO?

Wait until the review window you agreed on. If none was set, five business days. A polite reminder a few days after due, then a firmer operational note. For this combo, treat "3 days after due date" as the default, then adjust around launch calendars and review boards set speed. you don't. If you're emailing a CEO, Keep the whole note under 70 words unless they asked for detail. If they named a board week or a freeze, believe it and leave a reopen date.

What this CEO actually cares about

A CEO in Pharmaceuticals is protecting time, reputation, and optionality. They skim on a phone between meetings. If the first two lines don't name a business outcome, the rest never gets read. The hook that earns a look is a P&L, risk, or competitive issue they already feel. The ask should stay at this size: one decision or a 10-minute yes, not a workshop. Delete trigger: A long origin story or a request to 'pick your brain.' a P&L, risk, or competitive issue they already feel a P&L, risk, or competitive issue they already feel

How Pharmaceuticals changes the note

Pharmaceuticals buyers are commercial, medical, and ops leads who work under review boards and long timelines. Don't invent clinical claims. Don't treat HCPs like a funnel. If you don't know the rules, your email is a liability. A credible proof point in this vertical sounds like: cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Watch the language. Words that land here include MLR, label, access, HCP, congress, promotional review. If you cannot name a label update, a launch window, or a congress, wait until you can. If you cannot name a label update, a launch window, or a congress, wait until you can.

How should I customize this template before I send it?

Replace the pain line with an agency waiting on MLR while the sales team keeps asking 'is it approved yet'.
Keep the tone direct, adult, light on process jargon.
Quote the exact option names from the proposal so they don't reopen the PDF.
Time it for 3 days after due date. A polite reminder a few days after due, then a firmer operational note.
Don't use consumer-startup slang. It's a credibility leak.

What mistakes should I avoid with this after invoice note?

Asking 'any thoughts?' after a 12-page proposal invites silence.
Don't threaten, guilt, or bury the amount.
Don't use consumer-startup slang. It's a credibility leak.
A long origin story or a request to 'pick your brain.'

How does this after invoice scenario compare?

Dimension	For this template
Best send window	3 days after due date
Ideal length	Keep the whole note under 70 words unless they asked for detail.
Primary ask	one decision or a 10-minute yes, not a workshop
Industry metric to cite	time through MLR, access, and compliant engagement rates
Tone	Direct, adult, light on process jargon. Talk like a peer who did the homework.
Unlike proposal follow-up	The commercial terms were already accepted. You're in collections-lite, not sales.
Unlike apology	Only apologize if you invoiced wrong. Don't apologize for asking to be paid.

What should I copy and send?

Copy-ready template

Subject

[Company Name] / time through MLR

Body

Hi [First Name],

Checking whether the proposal is waiting on numbers, legal, or a person.

The version of this that matters for commercial, medical, and ops leads who work under review boards and long timelines is cut review cycles on a leave-behind by catching claims issues before legal saw the tenth draft. Most delays I see are one of four things: scope, price, timing, or who has to sign. Tell me which one and I'll rewrite that section today.

Get paid or learn the blocker: PO, coding, approval, or dispute.

If the answer is not now, I can archive this cleanly.

Best,
[Your Name]
[Your Title]
[Your Company]

Questions people ask before they hit send

Not as an opening move. Ask what's blocking the decision first. If budget is the issue, trim scope or phase the work. Discounting before you know the objection trains them to wait you out. Name the stall they care about, offer one small next step, and stop before the thread feels like a sequence.

Related templates

Want a custom draft instead? Try the email generator.